Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Metsera Inc (MTSR)

Metsera Inc (MTSR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,423,156
  • Shares Outstanding, K 105,293
  • Annual Sales, $ 0 K
  • Annual Income, $ -209,130 K
  • EBIT $ -179 M
  • EBITDA $ -179 M
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 22.01
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -5.21
  • Most Recent Earnings $-1.11 on 11/12/25
  • Next Earnings Date 11/17/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.00
  • Number of Estimates 1
  • High Estimate 0.00
  • Low Estimate 0.00
  • Prior Year -3.52
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.83 +36.01%
on 10/28/25
83.86 -15.93%
on 11/07/25
+17.53 (+33.09%)
since 10/13/25
3-Month
29.10 +142.27%
on 08/14/25
83.86 -15.93%
on 11/07/25
+39.63 (+128.38%)
since 08/13/25

Most Recent Stories

More News
These 3 Unusually Active Puts Deep ITM Offer Strategic Plays for Both Bulls and Bears

The markets are at a crossroads right now. It’s hard to know which way they’ll head. Corporate earnings suggest one thing; inflation suggests another. These three unusually active puts from Thursday...

META : 670.71 (+1.39%)
LULU : 188.87 (+2.87%)
MTSR : 70.50 (-0.35%)
STZ : 141.01 (+2.16%)
CORZ : 16.88 (-1.17%)
Pfizer Completes Acquisition of Metsera

Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape Complements and transforms...

MTSR : 70.50 (-0.35%)
PFE : 25.76 (+0.23%)
Stocks Finish Sharply Higher on Plans to Reopen the US Government

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +1.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.81%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.20%. December E-mini...

GOOGL : 320.87 (+1.02%)
AAPL : 280.30 (-0.14%)
ADI : 283.01 (+2.07%)
CLS : 323.90 (+0.34%)
ELV : 331.07 (-0.21%)
TSLA : 457.96 (+0.75%)
WDC : 165.32 (+2.68%)
AMD : 220.01 (+1.87%)
UPS : 95.47 (+0.75%)
SPY : 687.74 (+0.49%)
META : 670.71 (+1.39%)
UHS : 229.69 (-0.39%)
Stocks Supported by Hopes the US Government Will Soon Reopen

The S&P 500 Index ($SPX ) (SPY ) today is up +1.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.81%. December E-mini S&P futures (ESZ25...

AMAT : 270.88 (+0.53%)
GOOGL : 320.87 (+1.02%)
AAPL : 280.30 (-0.14%)
B : 42.04 (+2.76%)
GFI : 44.22 (+6.25%)
CLS : 323.90 (+0.34%)
$IUXX : 25,804.15 (+0.87%)
ELV : 331.07 (-0.21%)
ZNH26 : 112-215 (-0.04%)
MSFT : 481.79 (+0.20%)
MNDY : 158.42 (+2.36%)
TSLA : 457.96 (+0.75%)
Stocks Rally on Optimism that the US Government Will Soon Reopen

The S&P 500 Index ($SPX ) (SPY ) today is up +1.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.81%. December E-mini S&P futures (ESZ25...

GOOGL : 320.87 (+1.02%)
AAPL : 280.30 (-0.14%)
ADI : 283.01 (+2.07%)
CLS : 323.90 (+0.34%)
ELV : 331.07 (-0.21%)
TSLA : 457.96 (+0.75%)
WDC : 165.32 (+2.68%)
AMD : 220.01 (+1.87%)
SPY : 687.74 (+0.49%)
META : 670.71 (+1.39%)
UHS : 229.69 (-0.39%)
HCA : 486.32 (-0.27%)
Stocks Set to Open Sharply Higher as End to U.S. Government Shutdown Nears

December S&P 500 E-Mini futures (ESZ25) are up +0.92%, and December Nasdaq 100 E-Mini futures (NQZ25) are up +1.39% this morning as optimism that lawmakers are nearing a deal to end the longest government...

MSTR : 183.70 (-1.24%)
MARA : 12.08 (-2.89%)
AMAT : 270.88 (+0.53%)
NVDA : 182.67 (-0.39%)
MTSR : 70.50 (-0.35%)
CSCO : 77.96 (+0.26%)
GMED : 90.20 (+1.65%)
EXPE : 262.72 (+1.68%)
AKAM : 86.37 (-0.27%)
MU : 233.49 (+3.02%)
NQZ25 : 25,849.00 (+0.88%)
COIN : 271.49 (-0.93%)
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war against Novo Nordisk

MTSR : 70.50 (-0.35%)
PFE : 25.76 (+0.23%)
Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer

NEW YORK , Nov. 7, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ: MTSR) today announced that it has entered into an amended merger agreement with Pfizer, pursuant to which Pfizer will acquire Metsera...

MTSR : 70.50 (-0.35%)
Metsera Issues Statement in Response to Litigation Ruling

NEW YORK , Nov. 5, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ: MTSR) ("Metsera" or the "Company") today issued the following statement in response to a ruling in the litigation filed against the...

MTSR : 70.50 (-0.35%)
Wall Street gains ground amid steady flow of earnings reports, upbeat economic updates

Stocks gained ground on Wall Street following several upbeat economic updates and a steady flow of quarterly reports from U.S. companies

GOOGL : 320.87 (+1.02%)
AVGO : 389.19 (+2.14%)
EXPE : 262.72 (+1.68%)
AXON : 552.77 (+0.39%)
IFF : 67.70 (+1.82%)
$IUXX : 25,804.15 (+0.87%)
PFE : 25.76 (+0.23%)
MSFT : 481.79 (+0.20%)
TSLA : 457.96 (+0.75%)
QCOM : 175.35 (+0.57%)
AMD : 220.01 (+1.87%)
$DOWI : 48,065.82 (+0.45%)

Business Summary

Metsera Inc. is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight and related conditions. Metsera Inc. is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 71.46
2nd Resistance Point 71.12
1st Resistance Point 70.81
Last Price 70.50
1st Support Level 70.16
2nd Support Level 69.82
3rd Support Level 69.51

See More

52-Week High 83.86
Last Price 70.50
Fibonacci 61.8% 56.52
Fibonacci 50% 48.08
Fibonacci 38.2% 39.64
52-Week Low 12.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar